Salvianolic acid B protects against acute and chronic liver injury by inhibiting Smad2C/L phosphorylation.

liver injury nuclear factor erythroid-2-related factor 2/heme oxygenase-1 phosphorylated Smad2 at COOH-terminal/linker region salvianolic acid B

Journal

Experimental and therapeutic medicine
ISSN: 1792-0981
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 03 05 2019
accepted: 19 03 2020
entrez: 18 3 2021
pubmed: 19 3 2021
medline: 19 3 2021
Statut: ppublish

Résumé

Salvianolic acid B (Sal B) has strong antioxidant and anti-fibrosis effects, which are related to the transforming growth factor β/Smad signaling pathway. However, how Sal B affects this antioxidant pathway and the phosphorylation (p-) of Smad2 at both the COOH-terminal (pSmad2C) and linker region (pSmad2L) are unknown. The aims of the present study were to investigate the underlying mechanisms of Sal B on acute and chronic liver injury induced by CCl

Identifiants

pubmed: 33732314
doi: 10.3892/etm.2021.9772
pii: ETM-0-0-09772
pmc: PMC7903446
doi:

Types de publication

Journal Article

Langues

eng

Pagination

341

Informations de copyright

Copyright: © Tao et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Chin J Integr Med. 2012 Apr;18(4):316-20
pubmed: 22457144
J Food Sci. 2017 Aug;82(8):1953-1960
pubmed: 28753232
Annu Rev Pathol. 2011;6:425-56
pubmed: 21073339
Hepatol Res. 2000 Jul;18(1):63-71
pubmed: 10838037
Cell Tissue Res. 2012 Jan;347(1):225-43
pubmed: 21626291
Sci Rep. 2018 Sep 25;8(1):14327
pubmed: 30254303
World J Gastroenterol. 2014 Sep 14;20(34):12031-8
pubmed: 25232240
J Pharmacol Sci. 2019 Mar;139(3):166-173
pubmed: 30709701
BMC Cancer. 2014 Mar 25;14:220
pubmed: 24667059
Cells. 2019 Nov 11;8(11):
pubmed: 31718044
Nature. 2003 Oct 9;425(6958):577-84
pubmed: 14534577
Biochem Biophys Res Commun. 2012 Jun 1;422(2):344-50
pubmed: 22583898
Biochem Biophys Res Commun. 2018 Jan 1;495(1):325-331
pubmed: 29108993
Mediators Inflamm. 2016;2016:2748367
pubmed: 27293314
J Clin Med. 2016 Jan 12;5(1):
pubmed: 26771649
Am J Respir Crit Care Med. 2011 Oct 15;184(8):894-903
pubmed: 21799075
J Ethnopharmacol. 2014;151(1):198-209
pubmed: 24247078
J Pharmacol Sci. 2016 Jan;130(1):15-23
pubmed: 26810570
J Histochem Cytochem. 2016 Mar;64(3):157-67
pubmed: 26747705
Free Radic Biol Med. 2018 Aug 20;124:504-516
pubmed: 29966698
Drug Des Devel Ther. 2017 Jul 26;11:2179-2191
pubmed: 28794616
Free Radic Biol Med. 2012 Feb 1;52(3):671-682
pubmed: 22155056
Free Radic Res. 2012 Jun;46(6):758-65
pubmed: 22468959
Chin Med. 2015 Apr 15;10:7
pubmed: 25897319
J Ethnopharmacol. 2006 Apr 21;105(1-2):215-22
pubmed: 16314058
Redox Biol. 2015 Dec;6:565-577
pubmed: 26496488
J Physiol Pharmacol. 2008 Aug;59 Suppl 1:107-17
pubmed: 18802219
Hepatology. 1985 Mar-Apr;5(2):224-32
pubmed: 3979954
Chem Biol Interact. 2018 Aug 25;292:76-83
pubmed: 30017632
Toxicol Appl Pharmacol. 2009 Nov 1;240(3):377-84
pubmed: 19647758
Cell Mol Life Sci. 2010 Jun;67(12):2077-90
pubmed: 20213272
J Clin Transl Hepatol. 2014 Sep;2(3):170-5
pubmed: 26355537
Int J Oncol. 2014 Oct;45(4):1363-71
pubmed: 25050845
Exp Biol Med (Maywood). 2013 Nov 1;238(11):1284-96
pubmed: 24006304
Gut. 2007 Feb;56(2):284-92
pubmed: 17303605
Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S51-9
pubmed: 26189980
Am J Gastroenterol. 2003 May;98(5):960-7
pubmed: 12809815
Chem Biol Interact. 1989;72(1-2):1-56
pubmed: 2684438
Hepatol Res. 2009 Mar;39(3):290-300
pubmed: 19067753
Free Radic Biol Med. 2014 Apr;69:219-28
pubmed: 24486344
J Biol Chem. 2013 Jul 12;288(28):20658-67
pubmed: 23737527
Cell Mol Life Sci. 2016 Sep;73(17):3221-47
pubmed: 27100828
PLoS One. 2015 Jul 30;10(7):e0132978
pubmed: 26226105
Nat Biotechnol. 2012 Jan 15;30(2):179-83
pubmed: 22252509
Dig Liver Dis. 2007 Apr;39(4):293-304
pubmed: 17331820
Dig Dis Sci. 1999 Jun;44(6):1249-53
pubmed: 10389705
Redox Biol. 2015;4:180-3
pubmed: 25588755
Clin Biochem. 2010 Mar;43(4-5):424-9
pubmed: 19900435
Biomed Pharmacother. 2017 Nov;95:1-10
pubmed: 28826090

Auteurs

Xiang-Ming Tao (XM)

Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China.

Dong Li (D)

Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China.

Chong Zhang (C)

Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China.

Guang-Hua Wen (GH)

Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China.

Chao Wu (C)

Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China.

Yuan-Yuan Xu (YY)

Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China.

Yue Kan (Y)

Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China.

Wan-Peng Lu (WP)

Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China.

Han-Yan Ding (HY)

Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China.

Yan Yang (Y)

Department of Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Hefei, Anhui 230032, P.R. China.

Classifications MeSH